Here's the live share price of Accretion Nutraveda along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Accretion Nutraveda | 1.36 | 15.38 | 8.85 | 82.71 | 56.38 | 16.07 | 9.35 |
| Sun Pharmaceutical Industries | -0.72 | 0.57 | 4.83 | 12.85 | 19.30 | 19.47 | 19.96 |
| Divi's Laboratories | 2.34 | 23.25 | 28.62 | 38.09 | 43.35 | 31.81 | 11.72 |
| Torrent Pharmaceuticals | -2.16 | -1.17 | 11.64 | 19.81 | 34.78 | 35.38 | 27.42 |
| Zydus Lifesciences | 8.37 | 6.45 | 29.36 | 30.76 | 25.93 | 23.35 | 17.21 |
| Cipla | 0.80 | 2.44 | 13.12 | 9.93 | -3.89 | 5.77 | 10.06 |
| Lupin | -5.08 | -9.33 | 0.83 | 2.47 | 16.51 | 27.93 | 18.34 |
| Mankind Pharma | -1.12 | -3.37 | 1.99 | 16.63 | -0.26 | 10.07 | 11.23 |
| Dr. Reddy's Laboratories | 2.13 | -2.89 | -5.60 | -5.93 | -1.77 | 0.99 | 4.93 |
| Laurus Labs | -0.09 | 18.20 | 45.00 | 80.69 | 121.59 | 68.53 | 21.04 |
| Aurobindo Pharma | 3.20 | 7.44 | 11.84 | 43.83 | 57.37 | 24.07 | 15.06 |
| Biocon | 0.87 | 4.42 | 6.60 | 14.24 | 20.79 | 18.98 | 2.75 |
| Alkem Laboratories | -3.40 | -1.88 | -0.57 | -6.63 | 6.20 | 12.99 | 8.48 |
| Glenmark Pharmaceuticals | 1.07 | -1.27 | 0.74 | 11.70 | 10.46 | 41.76 | 31.82 |
| Abbott India | 1.61 | 2.91 | 4.77 | 5.60 | -12.87 | 6.08 | 8.70 |
| Anthem Biosciences | 6.32 | 17.48 | 9.70 | 24.90 | 18.09 | 6.33 | 3.75 |
| Gland Pharma | 12.92 | 16.83 | 53.54 | 58.35 | 49.20 | 21.50 | -7.81 |
| Ipca Laboratories | -0.39 | -3.51 | 16.41 | 19.29 | 27.88 | 25.81 | 8.09 |
| GlaxoSmithKline Pharmaceuticals | 2.09 | 8.39 | 7.03 | -1.75 | 1.20 | 22.77 | 10.27 |
| Ajanta Pharma | 3.03 | 3.48 | 14.62 | 22.63 | 31.23 | 27.03 | 18.78 |
Source: Dion Global
Over the last one year, Accretion Nutraveda has gained 56.38% compared to peers like Sun Pharmaceutical Industries (19.30%), Divi's Laboratories (43.35%), Torrent Pharmaceuticals (34.78%). From a 5 year perspective, Accretion Nutraveda has underperformed peers relative to Sun Pharmaceutical Industries (19.96%) and Divi's Laboratories (11.72%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 296.9 | 297.4 |
| 10 | 289.77 | 290.72 |
| 20 | 275.72 | 281.2 |
| 50 | 268.19 | 262.29 |
| 100 | 227.65 | 0 |
| 200 | 113.82 | 0 |
Source: Dion Global
In the latest quarter, Accretion Nutraveda remained same as its previous close in promoter holding, while DII stake decreased to 6.10%, FII holding unchanged at 1.08%, and public shareholding moved up to 19.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Aug 05, 2026, 04:40 AM IST IST | Accretion Nutraveda - Notice Of The 5Th AGM Of The Company |
| Aug 05, 2026, 04:35 AM IST IST | Accretion Nutraveda - Reg. 34 (1) Annual Report. |
| Jul 09, 2026, 07:38 PM IST IST | Accretion Nutraveda - Announcement Under Regulation 30 Of SEBI (LODR)- Award |
| Jul 06, 2026, 10:09 PM IST IST | Accretion Nutraveda - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| May 16, 2026, 12:29 AM IST IST | Accretion Nutraveda - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Source: Dion Global
Accretion Nutraveda Ltd. is a Public Limited Listed company incorporated on 16/03/2021 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24290GJ2021PLC121216 and registration number is 121216. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 33.60 Cr. and Equity Capital is Rs. 7.24 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Accretion Nutraveda is ₹299.00 as on Aug 12, 2026.
The Accretion Nutraveda is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Accretion Nutraveda is ₹216.48 Cr as on Aug 12, 2026.
Today’s highest and lowest price of Accretion Nutraveda are ₹299.00 and ₹299.00.
The 52-week high/low is the highest and lowest price at which Accretion Nutraveda stock has traded in the past 52-week or nearly a year. The 52-week high of Accretion Nutraveda is ₹303.50 and 52-week low of Accretion Nutraveda is ₹150.10 as on Aug 12, 2026.
The Accretion Nutraveda has shown returns of 0.0% over the past day, 15.38% for the past month, 8.85% over 3 months, 56.38% over 1 year, 16.07% across 3 years, and 9.35% over 5 years.
P/E ratio of and PB ratio of Accretion Nutraveda are 42.71 and 6.10 on Aug 12, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global